Dan Brennan
Stock Analyst at TD Cowen
(4.41)
# 383
Out of 4,761 analysts
104
Total ratings
53.57%
Success rate
19.05%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Reinstates: Buy | $74 | $68.09 | +8.68% | 2 | Feb 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $75 → $118 | $95.83 | +23.13% | 3 | Jan 7, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $49.26 | +74.58% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $162.31 | +7.82% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $163.02 | +53.36% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $50.82 | +37.74% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $94.20 | +87.90% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $113.84 | +26.49% | 3 | Nov 5, 2024 | |
| WAT Waters | Maintains: Hold | $363 → $410 | $374.82 | +9.39% | 3 | Nov 4, 2024 | |
| DHR Danaher | Maintains: Buy | $310 → $315 | $210.23 | +49.84% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $135.37 | +18.19% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $42.87 | -2.03% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8.5 → $11 | $4.11 | +167.64% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $14.18 | +111.57% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $17.30 | +79.19% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $532.55 | +23.56% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $42.76 | +19.27% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.88 | +217.46% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $11.10 | +80.18% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $10.90 | +193.58% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $358.97 | +52.10% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.86 | +276.34% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.54 | +874.03% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $201.39 | +15.20% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,286.54 | -31.60% | 3 | Oct 7, 2020 |
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $68.09
Upside: +8.68%
GeneDx Holdings
Jan 7, 2025
Maintains: Buy
Price Target: $75 → $118
Current: $95.83
Upside: +23.13%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $49.26
Upside: +74.58%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $162.31
Upside: +7.82%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $163.02
Upside: +53.36%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $50.82
Upside: +37.74%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $94.20
Upside: +87.90%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $113.84
Upside: +26.49%
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $374.82
Upside: +9.39%
Danaher
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $210.23
Upside: +49.84%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $135.37
Upside: +18.19%
Aug 8, 2024
Maintains: Buy
Price Target: $41 → $42
Current: $42.87
Upside: -2.03%
Aug 8, 2024
Maintains: Neutral
Price Target: $8.5 → $11
Current: $4.11
Upside: +167.64%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $14.18
Upside: +111.57%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $17.30
Upside: +79.19%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $532.55
Upside: +23.56%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $42.76
Upside: +19.27%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.88
Upside: +217.46%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $11.10
Upside: +80.18%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $10.90
Upside: +193.58%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $358.97
Upside: +52.10%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $1.86
Upside: +276.34%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.54
Upside: +874.03%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $201.39
Upside: +15.20%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,286.54
Upside: -31.60%